Health Canada
This article was originally published in The Tan Sheet
Executive Summary
Agency cautions consumers against use of Tao Chih Pien pediatric product with unlabeled aristolochic acid in Aug. 24 warning. Customs alert has been issued for item, manufactured by TianJin Medicines & Health Products Import & Export Corp. (China). Health Canada released a separate consumer reminder on aristolochic acid risks Aug. 17. Warning of potential interaction between OTC vaginal miconazole products and Rx blood-thinning agent warfarin also recently issued by agency, following similar FDA "Talk Paper" in March (1"The Tan Sheet" March 12, p. 4). Both agencies are asking manufacturers to add new warning statements to labeling
You may also be interested in...
Monistat Labeling To Carry Vaginal Miconazole/Warfarin Interaction Warning
Johnson & Johnson Personal Products will update the labeling for its miconazole-containing Monistat 3 and Monistat 7 yeast infection treatments within the year to note the possible interaction between vaginal miconazole and the Rx blood-thinning medication warfarin.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands